Immunogen reported $2.21M in Ordinary Share Capital for its third fiscal quarter of 2022.

Trading Economics members can view, download and compare data from nearly 200 countries, including more than 20 million economic indicators, exchange rates, government bond yields, stock indexes and commodity prices.

The Trading Economics Application Programming Interface (API) provides direct access to our data. It allows API clients to download millions of rows of historical data, to query our real-time economic calendar, subscribe to updates and receive quotes for currencies, commodities, stocks and bonds.

Please Paste this Code in your Website
Ordinary Share Capital Change
Agios Pharmaceuticals AGIO:US USD 71K 0
Amgen AMGN:US USD 32.37B 1.03B
Astellas Pharma 4503:JP JPY 103B 0
AstraZeneca AZN:LN USD 387M 0
Bluebird Bio BLUE:US USD 829K 94K
Bristol Myers Squibb BMY:US USD 292M 0
Eli Lilly And LLY:US USD 594.1M 0
Emergent Biosolutions EBS:US USD 100K 0
Exelixis EXEL:US USD 323K 1000
Halozyme Therapeutics HALO:US USD 135K 3K
Heron Therapeutics HRTX:US USD 1.19M 163K
Immunogen IMGN:US USD 2.21M 2K
Karyopharm Therapeutics KPTI:US USD 8K 0
Macrogenics MGNX:US USD 615K 0
Nektar Therapeutics NKTR:US USD 19K 0
Novartis NVS:US USD 890M 0
Regeneron Pharmaceuticals REGN:US USD 100K 0
Roche Holding ROG:VX 107M 53M
Seattle Genetics SGEN:US USD 185K 1000